We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Benjamin Derman MD

Benjamin Derman MD

Assistant Professor of Medicine, University of Chicago, Chicago, Illinois

Ben Derman, MD, is an Assistant Professor of Medicine at the University of Chicago, specializing in plasma cell disorders.  Along with his clinical practice, Dr. Derman’s research is focused on identifying strategies that can lead to a possible cure for multiple myeloma, including using minimal residual disease to guide decision making. Dr. Derman is also investigating new methods and therapies designed to improve outcomes and quality of life for his patients. Additionally, he is interested in evaluating reasons for racial disparities in multiple myeloma outcomes to better understand and care for those patients. His work has been published in several peer-reviewed journals, including the JAMA Oncology, Blood, Blood Advances, Blood Cancer Journal, Journal of Immunotherapy of Cancer, Leukemia, Leukemia and Lymphoma, and the British Journal of Haematology.


Disclosures: consultancy for Sanofi, Janssen, COTA Healthcare